Calling for Bold Pandemic Action at the EU-AU Summit

African and European civil society organizations (CSOs) call on leaders in advance of the African Union (AU) – European Union (EU) Summit on February 17-18, 2022, to show solidarity in ending not only the COVID-19 crisis but also responding to global epidemics including HIV, tuberculosis, and malaria and put in place mechanisms and resources to build resilience and prepare for future pandemics. It’s time for strong and sustained political will, collective alignment, and integrated end-to-end approaches. We call on leaders to adopt the following actions at the Summit:

  1. Tackle the crisis of inequitable access to COVID-19 vaccines, and support vaccination programs
  2. Address the crisis of inequitable access to COVID-19 tools, including tests, treatments, oxygen, and PPE
  3. Invest in and strengthen the research and development (R&D) capacity in Africa
  4. Support Africa’s mRNA Technology Transfer Hub and agree to waive intellectual property (IP) for COVID-19 vaccines and other medical tools
  5. Support health systems strengthening in African countries to enable prevention, detection and response to new and existing threats
  6. Reform and strengthen multilateralism

Humanity deserves a world where every country is equipped to end the COVID-19 crisis and every country is prepared to stop infectious disease outbreaks from becoming deadly and costly pandemics. 

Read the full letter.

Organizations are welcome to sign on to the letter by Feb. 17, 2022. If your organization would like to sign on, please reach out to Aminata Wurie.

Personal Protective Equipment for Frontline Health Workers: An Essential Component of Pandemic Preparedness & Response

In December 2020, Pandemic Action Network’s Pandemic Action Agenda series urged world leaders to strengthen global health security architecture and governance in key areas, including pandemic supplies, to increase accountability and ensure the world is better prepared for the next pandemic and to respond to COVID-19.

This brief takes stock of progress made since December 2020 to resolve the global personal protective equipment (PPE) access crisis, aims to assess supply and demand challenges specific to community health workers, and informs recommendations for world, regional, and national leaders to build a more reliable and sustainable emergency response supply chain for the future.

Today, we have compelling evidence of the risk of leaving frontline health workers unprotected or partially protected against COVID-19, and we still lack sustainable solutions. As we look toward year three of this pandemic and beyond, world, regional, and national leaders must learn the lessons of this crisis and continue to prioritize sufficient PPE for frontline health workers — especially those who serve the most vulnerable and hardest-to-reach populations.

Read the full brief here.

Pandemic R&D Agenda for Action: Fostering Innovation to End This Pandemic and Prepare for the Next One

As the world commences the third year of the COVID-19 pandemic, the case for investment in research and development (R&D) for medical countermeasures to prevent and combat emerging global health threats is stronger than ever. Despite tremendous scientific accomplishments in 2020-21, systemic gaps in pandemic-related R&D systems, supply chains, manufacturing, and delivery continue to stymie the roll-out of urgently needed technologies to all people who need them, everywhere, and are prolonging the pandemic.

COVID-19 and its variants have exposed longstanding market and systems failures and fragilities that pose barriers to timely and effective pandemic R&D. Not only do these persistent gaps threaten to undo progress achieved through the scientific breakthroughs, but they also exacerbate entrenched inequalities that leave the most vulnerable and disadvantaged people around the globe without access to lifesaving medical countermeasures and essential health services, and perpetuate gross power imbalances between high- and low-income nations. COVID-19 has also unleashed a multitude of actors in pandemic-related R&D across the innovation spectrum and across the globe, underscoring the growing need for more purposeful alignment, coordination, information-sharing, and transparency.

The world urgently needs a fit-for-purpose, proactive, and resilient pandemic R&D ecosystem. There is broad consensus that R&D is a vital component of building a world better equipped to prevent, prepare for, and respond to pandemic threats. Yet new investments in innovation will fail to meet their promise to save lives, prevent future global health emergencies, and build a healthier, safer world for all unless governments, international institutions, and industry are willing to heed the hard lessons of this pandemic and work together to fix these systemic failures and challenges.

Produced by Global Health Technologies Coalition and Pandemic Action Network with contributions by members of the Pandemic Action Network’s Pandemic Preparedness Working Group, this policy brief calls on world leaders to prioritize action in four key areas to close the critical R&D, manufacturing, and delivery gaps necessary to end the acute COVID-19 crisis and build a more resilient, equitable pandemic R&D ecosystem for the future.

Read the full brief here.